Aplix (TSE:3727) Research & Development: 円0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3727 Aplix Corp TSE:3727
49 GF Score
Price 円144.00
GF Value 円61.59
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Aplix Research & Development?

Aplix TSE:3727 -1.37% 49 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:3727 with a GF Score™ of 49/100 and a GF Value™ of 円61.59 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aplix's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Aplix  (TSE:3727) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aplix Research & Development Related Terms

Aplix Research & Development Historical Data

* Premium members only.

The historical data trend for Aplix's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aplix Research & Development Chart

Aplix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aplix Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3727
49GF Score
Aplix Corp TSE:3727
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aplix Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Aplix (TSE:3727) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Aplix and its competitors.
Is Aplix's Research & Development too high?
Aplix's current Research & Development is 円0 Mil. Overall, Aplix has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aplix's Research & Development compare to UBER and SHOP?
Aplix's Research & Development of 円0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aplix and its competitors. Aplix's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aplix stock overvalued right now?
Based on GuruFocus' analysis, Aplix (TSE:3727) is currently considered Significantly Overvalued. The stock's GF Value™ is 円61.59, compared to a current price of 円144.00 — trading 133.8% above its estimated fair value. The current Research & Development is 円0 Mil. Aplix's overall GF Score™ is 49/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aplix (TSE:3727), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aplix (TSE:3727) Overvalued in 2026?

Based on GuruFocus' analysis, Aplix stock appears to be overvalued. The current stock price of 円144.00 is trading 133.8% above its estimated GF Value™ of 円61.59. GuruFocus considers Aplix to be Significantly Overvalued.

Key valuation signals for TSE:3727:

  • Research & Development: 円0 Mil
  • GF Value™: 円61.59 vs. price of 円144.00 (133.8% above fair value)
  • GF Score™: 49/100 with 1 warning sign

No single metric tells the full story. See the TSE:3727 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aplix Business Description

Address 2-20-9 Nishiwaseda, Shinjuku-ku, Tokyo, JPN, 169-0051
Aplix Corp is a Japan-based company engaged in the technology business. It specializes in developing technologies that connect various devices to the Internet of Things (IoT), enhancing convenience and quality of life for its customers. The company offers a range of services including stock business solutions and system development, focusing on custom development and support services. The product portfolio includes cloud services, AI-enabled dash cameras, and IoT data communication services, catering to diverse client needs. The company aims to provide reliable solutions for sectors such as manufacturing, mobility, smart homes, healthcare, and infrastructure.
49GF Score

Get the complete analysis for TSE:3727

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円144.00
Price
円61.59
GF Value